Diabetes

Top Story

ATMOSPHERE: Aliskiren fails to benefit patients with HF, diabetes vs. enalapril

May 26, 2016

In patients with diabetes and HF, the direct renin inhibitor aliskiren did not significantly improve outcomes compared with the ACE inhibitor enalapril, according to new data from the ATMOSPHERE trial.

In the overall results, presented in April, aliskiren (Tekturna, Novartis) alone or combined with enalapril did not improve CV mortality or hospitalization for HF compared with enalapril alone.

Meeting News Coverage

Insulin resistance a culprit for non-alcoholic fatty liver disease

May 21, 2016
NEW ORLEANS — The prevalence of nonalcoholic fatty liver disease is high in patients with diabetes, and insulin resistance is a common cause, according to a…
Meeting News Coverage

Despite guideline changes, statin use unchanged or lower in patients with diabetes

May 21, 2016
NEW ORLEANS — The rate of statin use in adults with diabetes has remained steady or declined since 2014, according to findings presented at the National Lipid…
Trial Scorecards

Trial Scorecard: STAMPEDE

Cardiology Today, May 2016
Researchers compared outcomes of intensive medical therapy, Roux-en-Y gastric bypass surgery or sleeve gastrectomy in patients with mild to moderate obesity and type 2…
CME

The Patient With Severe Hypertriglyceridemia

No commercial support for this activity.

Elevated serum triglycerides are a highly prevalent yet modifiable risk factor for atherosclerotic disease and its…
More »
Video
Meeting News Coverage

VIDEO: PEGASUS-TIMI 54 analysis shows reduced risk for MACE in patients with diabetes

April 7, 2016
More »
Featured
Highlights from ACC Scientific Session

Highlights from ACC Scientific Session

Video
Meeting News Coverage

VIDEO: Changing landscape of diabetes care explored at CMHC 2015

October 24, 2015
More »
CMEVIDEO

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

December 23, 2015 Expires: 12/22/2016
Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic burden. Preexisting conditions –…

This activity is supported by an educational grant from Merck & Co.

FDA News

REMS no longer needed for medicines containing rosiglitazone

December 16, 2015
The FDA today announced that it is eliminating the Risk Evaluation and Mitigation Strategy for rosiglitazone-containing type 2 diabetes medications…

In the Journals

Metformin may improve CV risk profile in patients at risk for diabetes

December 16, 2015
Four months of metformin therapy modestly improved the cardiovascular risk profile in patients with ST-elevation myocardial infarction, or STEMI, at…

Meeting News CoverageVideo

VIDEO: Daniel P. Kelly, MD, details ‘vicious cycle’ between obesity, diabetes and CVD

December 15, 2015
ORLANDO, Fla. — Daniel P. Kelly, MD, scientific director at the Sanford Burnham Prebys Medical Discovery Institute in Orlando, Florida, delves…

CME

The High-risk Patient with Dyslipidemia

December 16, 2015 Expires: 12/15/2016
As many as 40% to 50% of Americans are estimated to have lipid abnormalities including elevated low-density lipoprotein cholesterol (LDL-C), low…

No commercial support for this activity.

In the JournalsPerspective

Combat injury severity linked to elevated risk for hypertension, CAD, diabetes, CKD

December 14, 2015
A retrospective study of U.S. veterans of combat operations in Iraq and Afghanistan showed that the more severe a veteran’s combat injury, the…

Mexican societies to establish network affiliated with ACC's PINNACLE registry

December 12, 2015
The American College of Cardiology and two Mexican societies signed an agreement to make Mexico the fourth country outside the United States to…

In the Journals

Moderate-intensity statins may reduce heart failure in type 2 diabetes

December 8, 2015
Moderate-intensity statin therapy reduced heart failure incidence in type 2 diabetes compared with low-intensity or no statin, according to recent…

In the JournalsPerspective

AHA: Women with type 2 diabetes have higher CHD risk than men

December 7, 2015
Among patients with type 2 diabetes, women are twice as likely to have CHD as men, and may require more physical activity to mitigate that risk,

Meeting News Coverage

‘Burst’ exercise regimen improves cardiometabolic parameters in patients with diabetes

December 2, 2015
ORLANDO, Fla. — Patients with diabetes experienced greater improvements to HbA1c, cholesterol and BMI with a regimen of short periods of…

More Headlines »
morganatic-roan morganatic-roan